These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31755841)

  • 21. Fentanyl buccal tablet for the treatment of cancer-related breakthrough pain.
    Mercadante S
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):9-13. PubMed ID: 25359295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of wound-related procedural pain (volitional incident pain) in advanced illness.
    Gallagher R
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):80-5. PubMed ID: 23150425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies.
    Triarico S; Capozza MA; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
    Support Care Cancer; 2019 Oct; 27(10):3639-3645. PubMed ID: 31154533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl Buccal Soluble Film: A Review in Breakthrough Cancer Pain.
    Garnock-Jones KP
    Clin Drug Investig; 2016 May; 36(5):413-9. PubMed ID: 27007271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacoeconomics of breakthrough cancer pain.
    Kuo KL; Saokaew S; Stenehjem DD
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):167-75. PubMed ID: 23688496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fentanyl buccal tablet: rapid relief from breakthrough pain.
    Taylor DR
    Expert Opin Pharmacother; 2007 Dec; 8(17):3043-51. PubMed ID: 18001263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer breakthrough pain. Indications for rapidly effective opioids].
    Kessler J; Bardenheuer HJ
    Anaesthesist; 2011 Jul; 60(7):674-82. PubMed ID: 21491140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grading clinical guidelines for the use of transmucosal immediate-release fentanyl products in breakthrough pain.
    Handsaker S; Dempsey L; Fabby C
    Int J Palliat Nurs; 2013 Feb; 19(2):60-5. PubMed ID: 23435534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for breakthrough cancer pain.
    Mercadante S
    Drugs; 2012 Jan; 72(2):181-90. PubMed ID: 22233484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project.
    Zeppetella G
    Palliat Med; 2011 Jul; 25(5):516-24. PubMed ID: 21708858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transmucosal fentanyl administration: sublingual, buccal, nasal - all the same? Treatment of breakthrough cancer pain].
    Überall MA
    MMW Fortschr Med; 2017 Oct; 159(Suppl 6):15-22. PubMed ID: 29557092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer pain.
    Kleeberg UR; Davies A; Jarosz J; Mercadante S; Poulain P; O'Brien T; Schneid H; Kress HG
    Eur J Pain; 2015 Apr; 19(4):528-37. PubMed ID: 25181451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.
    Mercadante S; Adile C; Cuomo A; Aielli F; Cortegiani A; Casuccio A; Porzio G
    J Pain Symptom Manage; 2015 Nov; 50(5):579-86. PubMed ID: 26303188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carer preferences of route of administration of transmucosal diamorphine and willingness to take part in a randomised controlled trial: an interview study (DIPPER).
    Jamieson L; Harrop E; Liossi C; Boyce K; Mitchell L; Johnson M; Jani Y; Akinyooye V; Skene SS; Wong ICK; Howard RF; Oulton K
    BMC Palliat Care; 2022 May; 21(1):78. PubMed ID: 35581660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.
    Mercadante S; Ferrera P; Arcuri E
    Support Care Cancer; 2011 Mar; 19(3):435-8. PubMed ID: 20882391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
    Prescrire Int; 2009 Oct; 18(103):205. PubMed ID: 19882786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.